Table 1 Basic characteristics of patients with diabetes and controls included in the study
Variable | Controls (n = 28) | Patients with diabetes mellitus type 1 (n = 30) | Patients with diabetes mellitus type 2 (n = 34) |
|---|---|---|---|
Age (years) | 36.8 (+/− 13.2) | 47.5 (+/− 14.4) | 62.4 (+/− 11.9) |
Males (%) | 8 (28.5%) | 12 (40%) | 20 (58.8%) |
BMI (kg/m²) | 27.7 (+/− 6.4) | 27.8 (+/− 5.5) | 36.0 (+/− 10.3) |
SAGEs | 1.58 (+/− 0.43) | 2.11 (+/− 0.52) | 2.53 (+/− 0.65) |
HbA1c (%) | 5.33 (+/− 0.35) | 8.10 (+/− 1.17) | 7.42 (+/− 1.83) |
Cholesterol (mg/dl) | 181.7 (+/− 45.2) | 179.7 (+/− 33.6) | 164.4 (+/− 40.1) |
LDL (mg/dl) | 117.5 (+/− 33.2) | 107.9 (+/− 28.8) | 95.2 (+/− 36.4) |
Triglycerides (mg/dl) | 109.2 (+/− 78.3) | 106.8 (+/− 79.0) | 159.7 (+/− 113.1) |
CAP (dB/m)* | 251.5 (+/− 69.6) | 240.4 (+/− 62.9) | 309.4 (+/− 65.1) |
LSM (kPa)* | 5.9 (+/− 1.9) | 4.7 (+/− 1.4) | 9.7 (+/− 5.3) |
FGF19 (pg/ml) | 179.01 (+/− 116.1) | 181.7 (+/− 88.7) | 123.1 (+/− 86.1) |
FGF21(pg/ml) | 235.6 (+/− 322.4) | 236.7 (+/− 369.7) | 390.4 (+/− 394.7) |
GDF15 (pg/ml) | 441.7 (+/− 335.2) | 1005.4 (+/− 996.9) | 1840.2 (+/− 1140.8) |
IGF1 (ng/ml) | 146.4 (+/− 48.4) | 111.6 (+/− 39.9) | 120.65 (+/− 43.5) |
IGFBP3 (µg/ml) | 5.48 (+/− 0.9) | 4.1 (+/− 1.2) | 4.08 (+/− 1.3) |